JFJane K. Fieldhouse

Jane K. Fieldhouse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jane K. Fieldhouse has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Disinvesting in the future leadership of global health has already begun: What can we do about it?

    by Shashika Bandara, Jane K. Fieldhouse, Inosha Alwis, Lucía Abascal Miguel, Canice Christian, Nelson Evaborhene

    Following the abrupt and significant funding cuts by the U.S. and increasing retreat by high-income countries from development aid for health, global health as a field requires reimagining and urgent solution building by all parties involved. In this essay, we aim to draw attention to an important and urgent challenge that deeply affects our collective future: the destruction of global health training opportunities and the weakening of future global health leadership . If we do not approach this challenge with a sense of urgency, global health research and training face irreversible shifts, weakening global preparedness to face future pandemics, address climate crisis, and achieve global goals such as universal health coverage or health for all. We outline existing best practices that we can build on and pathways to build better approaches in global health training.


  • Open Access

    The intersection of artificial intelligence with qualitative or mixed methods for communicable disease research: a scoping review

    by Jane K. Fieldhouse, Jianye Ge, Nistara Randhawa, David Wolking, Brooke N. Genovese, Jonna A.K. Mazet, Angel Desai


  • Open Access

    An analysis of One Health timeliness metrics across multisectoral public health emergencies in Uganda

    by Jane K. Fieldhouse, Lydia Nakiire, Joshua Kayiwa, Ali Mirzazadeh, Claire D. Brindis, Ashley Mitchell, Jaime Sepulveda, Issa Makumbi, Alex Riolexus Ario, Elizabeth Fair, et al.

    Background: Timeliness metrics offer countries a framework by which to assess and optimize speed in outbreak detection and response times. This study analyses the One Health timeliness metrics for multisectoral public health emergencies in Uganda to identify and explore factors influencing outbreak performance. Methods: We compiled a database of outbreak events in Uganda occurring between 2018-2022 and involving the human, animal, plant, and environmental sectors. Outbreak milestone dates were extracted from reports to calculate timeliness metrics, which were analyzed using proportional hazards regression models. Concurrently, we conducted Key Informant Interviews to explore factors affecting detection and response timeliness. Results: Integrated analyses of timeliness metrics from 81 outbreaks and expert interviews reveal that the greatest predictors of improved timeliness are frequent past experience with similar disease outbreaks and whether an outbreak is a viral hemorrhagic fever due to heightened perceived threat and pre-existing preparedness measures. Other factors, including diagnostic and laboratory considerations and contextual influences, such as One Health collaborations, are also described as relevant to timeliness. Conclusions: To complement positive timeliness trends in Uganda, disease-agnostic investments in outbreak preparedness and response efforts will facilitate the ability of health systems to rapidly detect and respond to all outbreaks, irrespective of the pathogen.


  • Open Access

    Bridging Language Barriers in COVID-19 Research: Descriptive Study of AccesoCovid.com’s Reach and User Engagement

    by Lucía Abascal Miguel, Maeve Forster, Sarah Gallalee, Mariam Carson, Jane K Fieldhouse, Alexandra Keir, Sigal Maya, Sabahat Rahman, Michael J A Reid, Hariclea Vasilopoulos, et al.

    Background: The COVID-19 pandemic underscored the challenge of swiftly disseminating research findings to a global audience. Language barriers further exacerbated disparities in access to timely scientific information, particularly for non-English speaking communities. The majority of COVID-19 research was published in English, limiting accessibility for Spanish-speaking populations. Objective: This paper aims to assess the reach and effectiveness of AccesoCovid.com, a platform designed to disseminate up-to-date COVID-19 research in both English and Spanish, addressing the language gap in scientific communication. Methods: AccesoCovid.com was developed through a partnership between the University of California, San Francisco (UCSF) and Universidad Nacional Autónoma de México (UNAM). The website’s performance and user engagement were evaluated using Google Analytics over a span of 2 years. Key metrics included user language preference, geographical distribution, and site traffic. The website summarized and translated 1032 articles on various COVID-19 topics, such as “Pharmaceutical Interventions and Vaccines.” Results: From February 2021 to February 2023, the platform attracted 57,000 users. Of the 43,000 unique new visitors, 84.2% (n=36,219) hailed from Spanish-speaking regions. The majority accessed the site organically through search engines, with 88.4% (n=38,000) of users arriving this way, while 5000 (11.6%) users accessed the site directly. Most users (n=30,894, 72.1%) preferred the Spanish version of the site. The website’s most accessed category was “Pharmaceutical Interventions and Vaccines,” followed by “Clinical Presentation and Management” and “Mental Health.” Regarding language distribution, 72.1% (n=30,894) of users primarily used Spanish; 21.4% (n=9215) used English; and 6.7% (n=2891) spoke other languages, including Portuguese, Chinese, and German. Geographically, the website attracted visitors from 179 countries, with the highest visitor counts from Mexico (n=12,342, 28.7%), Spain (n=6405, 14.9%), the United States (n=4416, 10.3%), and Peru (n=3821, 8.9%). Conclusions: AccesoCovid.com successfully bridged a critical language gap in the dissemination of COVID-19 research. Its success underscores the pressing need for multilingual scientific resources. The platform demonstrated significant user engagement and reach, particularly in Spanish-speaking countries. This highlights the potential for similar platforms to ensure equitable access to scientific knowledge across diverse linguistic communities. Future efforts should focus on expanding to other languages and conducting formal evaluations to enhance user satisfaction and impact.

  • Open Access

    How feasible or useful are timeliness metrics as a tool to optimise One Health outbreak responses?

    by Jane Fieldhouse, Lydia Nakiire, Joshua Kayiwa, Claire D Brindis, Ashley Mitchell, Issa Makumbi, Alex Riolexus Ario, Elizabeth Fair, Jonna A K Mazet, Mohammed Lamorde

    Introduction As timeliness metrics gain traction to assess and optimise outbreak detection and response performance, implementation and scale-up require insight into the perspectives of stakeholders adopting these tools. This study sought to characterise the feasibility and utility of tracking One Health outbreak milestones across relevant human, animal, plant, and environmental sectors to systematically quantify timeliness metrics in Uganda, a country prone to outbreaks of WHO priority diseases. Methods A database of outbreak events occurring in Uganda between 2018 and 2022 was compiled. Outbreak reports meeting our inclusion criteria were reviewed to quantify the frequency of milestone reporting. Key informant interviews were conducted with expert stakeholders to explore the feasibility and utility of tracking metrics using a framework analysis. Quantitative and qualitative data were collected and analysed concurrently. Results Of the 282 public health emergencies occurring between 2018 and 2022, 129 events met our inclusion criteria, and complete data were available for 82 outbreaks. For our qualitative portion, 10 informants were interviewed from 7 institutions, representing the human, animal and environmental sectors. Informants agreed most One Health milestones are feasible to track, which was supported by the frequency of milestone reporting; however, there was a demonstrated need for increased reporting of after-action reviews, as well as outbreak start and end dates. Predictive alerts signalling potential outbreaks and preventive responses to alerts are seen as challenging to routinely capture, reflecting the lack of public health action for these domains. Conclusion Despite consensus among stakeholders that timeliness metrics are a beneficial tool to assess outbreak performance, not all One Health metrics are being tracked consistently, thereby missing opportunities to optimise epidemic intelligence, preparedness and prevention. The feasibility of tracking these metrics depends on the integration of reporting channels, enhanced documentation of milestones and development of guidance for early adopters, recognising country-specific on-the-ground realities and challenges to national scaling efforts.


  • Open Access

    Bridging Language Barriers in COVID-19 Research: Descriptive Study of AccesoCovid.com’s Reach and User Engagement (Preprint)

    by Lucía Abascal Miguel, Maeve Forster, Sarah Gallalee, Mariam Carson, Jane K Fieldhouse, Alexandra Keir, Sigal Maya, Sabahat Rahman, Michael J A Reid, Hariclea Vasilopoulos, et al.

    BACKGROUND The COVID-19 pandemic underscored the challenge of swiftly disseminating research findings to a global audience. Language barriers further exacerbated disparities in access to timely scientific information, particularly for non-English speaking communities. The majority of COVID-19 research was published in English, limiting accessibility for Spanish-speaking populations. OBJECTIVE This paper aims to assess the reach and effectiveness of AccesoCovid.com, a platform designed to disseminate up-to-date COVID-19 research in both English and Spanish, addressing the language gap in scientific communication. METHODS AccesoCovid.com was developed through a partnership between the University of California, San Francisco (UCSF) and Universidad Nacional Autónoma de México (UNAM). The website’s performance and user engagement were evaluated using Google Analytics over a span of 2 years. Key metrics included user language preference, geographical distribution, and site traffic. The website summarized and translated 1032 articles on various COVID-19 topics, such as “Pharmaceutical Interventions and Vaccines.” RESULTS From February 2021 to February 2023, the platform attracted 57,000 users. Of the 43,000 unique new visitors, 84.2% (n=36,219) hailed from Spanish-speaking regions. The majority accessed the site organically through search engines, with 88.4% (n=38,000) of users arriving this way, while 5000 (11.6%) users accessed the site directly. Most users (n=30,894, 72.1%) preferred the Spanish version of the site. The website’s most accessed category was “Pharmaceutical Interventions and Vaccines,” followed by “Clinical Presentation and Management” and “Mental Health.” Regarding language distribution, 72.1% (n=30,894) of users primarily used Spanish; 21.4% (n=9215) used English; and 6.7% (n=2891) spoke other languages, including Portuguese, Chinese, and German. Geographically, the website attracted visitors from 179 countries, with the highest visitor counts from Mexico (n=12,342, 28.7%), Spain (n=6405, 14.9%), the United States (n=4416, 10.3%), and Peru (n=3821, 8.9%). CONCLUSIONS AccesoCovid.com successfully bridged a critical language gap in the dissemination of COVID-19 research. Its success underscores the pressing need for multilingual scientific resources. The platform demonstrated significant user engagement and reach, particularly in Spanish-speaking countries. This highlights the potential for similar platforms to ensure equitable access to scientific knowledge across diverse linguistic communities. Future efforts should focus on expanding to other languages and conducting formal evaluations to enhance user satisfaction and impact.

  • Open Access

    One Health timeliness metrics to track and evaluate outbreak response reporting: A scoping review

    by Jane K. Fieldhouse, Nistara Randhawa, Elizabeth Fair, Brian Bird, Woutrina Smith, Jonna A.K. Mazet


  • Open Access

    Panspecies molecular assays detect viral pathogens missed by real-time PCR/reverse-transcriptase PCR among pneumonia patients, Sarawak, Malaysia

    by Jane K. Fieldhouse, Emily S. Bailey, Teck-Hock Toh, King-Ching Hii, Kerry A. Mallinson, Jakie Ting, John A. Lednicky, Antoinette Berita, Tham Thi Nguyen, Diego Galan, et al.

    Background: In a year-long pneumonia etiology study conducted June 2017 to May 2018 in Sarawak, Malaysia, 599 patients’ nasopharyngeal swab specimens were studied with real-time polymerase chain reaction (rPCR)/ reverse-transcription (rRT-PCR) assays for respiratory pathogens known to contribute to the high burden of lower respiratory tract infections. The study team sought to compare real-time assay results with panspecies conventional molecular diagnostics to compare sensitivities and learn if novel viruses had been missed.Methods: Specimens were studied for evidence of adenovirus (AdV), enterovirus (EV) and coronavirus (CoV) with panspecies gel-based nested PCR/RT-PCR assays. Gene sequences of specimens positive by panspecies assays were sequenced and studied with the NCBI Basic Local Alignment Search Tool software.Results: There was considerable discordance between real-time and conventional molecular methods. The real-time AdV assay found a positivity of 10.4%; however, the AdV panspecies assay detected a positivity of 12.4% and the conventional AdV-Hexon assay detected a positivity of 19.6%. The CoV and EV panspecies assays similarly detected more positive specimens than the real-time assays, with a positivity of 7.8% by the CoV panspecies assay versus 4.2% by rRT-PCR, and 8.0% by the EV panspecies assay versus 1.0% by rRT-PCR. We were not able to ascertain virus viability in this setting. While most discordance was likely due to assay sensitivity for previously described human viruses, two novel, possible zoonotic AdV were detected.Conclusions: The observed differences in the two modes of amplification suggest that where a problem with sensitivity is suspected, real-time assay results might be supplemented with panspecies conventional PCR/RT-PCR assays.


  • Open Access

    First sequence of influenza D virus identified in poultry farm bioaerosols in Sarawak, Malaysia

    by Emily S. Bailey, Jane K. Fieldhouse, Natalie A. Alarja, David D. Chen, Maria E. Kovalik, Juliana N. Zemke, Jessica Y. Choi, Laura K. Borkenhagen, Teck-Hock Toh, Jeffrey Soon Yit Lee, et al.

    In 2018, our team collected aerosols samples from five poultry farms in Malaysia. Influenza D virus was detected in 14% of samples. One sample had an 86.3% identity score similar to NCBI accession number MH785020.1. This is the first molecular sequence of influenza D virus detected in Southeast Asia from a bioaerosol sample. Our findings indicate that further study of role of IDV in poultry is necessary.


  • Open Access

    High Prevalence of Viral Infections Among Hospitalized Pneumonia Patients in Equatorial Sarawak, Malaysia

    by Teck-Hock Toh, King-Ching Hii, Jane K Fieldhouse, Jakie Ting, Antoinette Berita, Tham Thi Nguyen, See-Chang Wong, Toh-Mee Wong, Wei-Honn Lim, Siaw-Jing Ha, et al.

    Background: Although pneumonia is a known cause of morbidity and mortality in Sarawak, Malaysia, the etiology and epidemiology of pneumonia are not well described in this equatorial region. Routine clinical diagnostics for pneumonia etiology at government hospitals in Sarawak had historically involved only bacterial diagnostics. Viral diagnostics were only obtained through outside consultations. Methods: From June 15, 2017 to May 14, 2018, we collected nasopharyngeal swabs from 600 patients of all ages older than 1 month hospitalized with pneumonia at Sibu and Kapit Hospitals. Specimens were examined at our collaborating institutions with a panel of molecular assays for viral pathogens including influenza A (IAV), IBV, ICV, and IDV, human adenovirus (AdV), human enterovirus (EV), human coronavirus (CoV), respiratory syncytial virus subtype A (RSV-A) or RSV-B, and parainfluenza virus (PIV) types 1–4. Results: Of 599 samples examined, 288 (48%) had molecular evidence of 1 or more respiratory viruses. Overall, the most prevalent virus detected was RSV-A (14.2%) followed by AdV (10.4%) and IAV (10.4%), then RSV-B (6.2%), EV (4.2%), IBV (2.2%), PIV-3 (1.7%), CoV (1.0%), PIV-1 (1.0%), PIV-4 (0.7%), and PIV-2 (0.2%). No specimens were confirmed positive for ICV or IDV. Conclusions: The high prevalence of viruses detected in this study suggest that respiratory viruses may be responsible for considerable morbidity in equatorial regions such as Sarawak. Access to viral diagnostics are very necessary for medical staff to determine appropriate pneumonia treatments.